Current Price Status
Stock is in Momentum
Stock is currently overvalued by the market with the expectation of annual earning growth at 248.35% to match current price.
Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- SUNZEN current price is INF% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedSUNZEN past 5-day return lagged behind the Pharmaceuticals industry average return by 2.89%
Below 30-Day AverageCurrent price RM0.22 is below 30-day average RM0.23 by 4.5%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Positive Revenue Growth
SUNZEN managed to achieve better revenue growth for past 2 quarters by average +49%.
Continued Losing Money
SUNZEN has been losing money in the 5 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
SUNZEN recent daily traded volume is -57.14% lower than past month average.
|Past 30-Day||Past 5-Day|
|63k daily||27k daily|
Price History Chart
Past 30-day Average Price: RM0.23
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stocks that has more than two consecutive money-losing quarters
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Stock Company Profile
SUNZEN BIOTECH BHD
Sunzen Biotech Bhd. is an investment holding company, which engages in the biotechnology research and development, manufacture, and marketing of animal feed supplement products. It operates through the Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Food ingredients products. The company was founded by Tan Kim Sing, Teo Kim Lai, Kok Poe Chu, and Fong Chan Seng on February 8, 2005 and is headquartered in Shah Alam, Malaysia.